Episode Overview

The American Cancer Society estimates more than 2 million new cancer cases in the United States in 2026, underscoring the need for strong cancer service lines. Meeting that need takes more than treatment capabilities.  It requires timely diagnosis, access to specialists, and coordinated care throughout the patient journey.


In this episode of Value-Based Care Insights, host Daniel J. Marino joins Elizabeth Liebow, Principal at ECG Management Consultants, to explore how health systems can build sustainable cancer service lines. Their discussion covers aligning investments with community needs, expanding access through strategic partnerships, and reducing delays through patient navigation and primary care integration—from initial concern through treatment and survivorship.

LISTEN TO THE EPISODE:

 

Host:

Dan headshot blue-1
Daniel J. Marino

Principal, ECG Management Consultants

 

Guest:

Elizabeth headshot

Elizabeth Liebow

Principal, ECG Management Consultants

Daniel Marino:

Welcome to Value-Based Care Insights. I am your host, Daniel Marino. Cancer care, for many hospitals and healthcare organizations, continues to be an important area of focus, both in terms of serving the community, but also the economic impact that cancer has to a hospital or to a health system. Many organizations are looking to expand many service lines, not just cancer. Many organizations, hospitals, health systems are focusing on expanding orthopedics, an orthopedic service line, gastroenterology. But cancer services, oncology, program, certainly is an area of great focus. Mostly because of the continued changing dynamics that influences cancer, and cancer services. Not only is access an issue, and really with patients navigating a lot of the cancer activities, but there's certain… an emotional influence that is driving a lot of our cancer services, and certainly patients within a cancer program. But also, what we're seeing is there's an increasing demand for strong diagnostic and therapeutic cancer care, and at the same time, we continue to see a shortage of cancer providers, all of which, again, makes the development of a robust, community-based, if you will, cancer program a bit challenging for healthcare organizations.

Well, I'm excited today to have one of my colleagues, a national expert in cancer care, cancer programs, cancer services, Elizabeth Liebow. She is a principal at ECG Management Consultants. She has more than 25 years of experience in healthcare strategy, system growth, performance improvement. She has helped numerous organizations develop their cancer service lines, and really helped to think through what that transformation is, and really expanding a lot of the cancer services to patients and to the community. Elizabeth, welcome to the program.

 

Elizabeth:

Thank you so much, Dan. It's great to be here.

 

Daniel Marino:

So, Elizabeth, when you look around the country, and you're seeing where organizations are on really wanting to expand their cancer services, meet the needs of their patients, of the communities. What do you see are some of the biggest challenges for these organizations as they think through how to expand?

 

Elizabeth:

So, we work with organizations from very rural, small systems in rural parts of the country to some of the biggest cancer centers in the world. And no organization, even the largest cancer centers, can be all things to all people in all aspects of cancer. Every one of them has partnerships. And that's largely because cancer is for the most part, a local disease. When people are really sick, they want to get care close to home. But it's not really one disease, it's many diseases. Some are common, some are rare, and so it's hard to treat all patients near home. Some need a specialized center, and cancer care is highly specialized. So, having… having the ability to treat multiple kinds of cancer is something that some places have and some don't. And then, finally cancer, both diagnosis and treatment, are evolving at lightning speed.

 

Daniel Marino:

Oh, yeah.

 

Elizabeth:

Life-saving ways. So all of those things together make it very, very complex.

 

Daniel Marino:

Well, especially the diagnostic and the treatments that are occurring. It seems like you know, every… every time you're reading the news, there's a new study, there's a new treatment that has been approved by the FDA, or is in process. So I think, to a certain extent, it provides that challenge to the healthcare organization, to the provider community, to, I think, one, think about what they need to focus on, and what subspecialty of medical oncology, if you will, that they need to focus on in support of what's occurring in the community, but also keeping up with the changes. How do you work with organizations to kind of think about how to create that path towards their continued development of their cancer service lines?

 

Elizabeth:

I think the first question for most organizations is, what is their vision of cancer care for their particular community and where they sit in their community? Are they a referral center? Are they a community system that wants to treat the vast majority of the common cancers, and then have a partnership for the more complex cancers. So, often, we'll suggest that they start with a demographic assessment. What is… what does cancer incidents look like in their community today? What are the projections? And they're… they're very… pretty easy to get, projections around cancer for the next 3, 5, 10 years. And then, what does their system look like? What kind of providers do they have? Are they having trouble recruiting? And then, based on that, we'll make a… often make a recommendation that either, you know, they… they really, our staff themselves and equip themselves with equipment, too, to be able to treat the common cancers, or to sub-specialize in some areas, or to develop partnerships with other places that do a lot of, you know, the more… the rare cancers.

 

Daniel Marino:

I'm… I'm… and many of the healthcare leaders, that I speak to around the country, like with many specialties, in oncology services and in cancer services, there's a shortage of providers. But not only is there a shortage, it seems like…the demand for cancer services has increased. And maybe it's because we're doing a better job of identifying these cancers early. Maybe it's because, I don't know, there's certain things that are happening in the environment that are creating maybe more different, more types of cancers. What are you seeing, or what do you believe is the drive for this increase in demand? Any thoughts?

 

Elizabeth:

Yeah, it… a lot of thoughts, and it's a great, great question. By far the biggest driver is purely simple demographics. The population is aging, cancer is largely a disease of aging, and as the last of the baby boomers hit the age where cancer is most common, we're seeing an explosion. But not just in older folks, there are many more diagnoses in younger people, and it's not entirely clear why that's happening. Some of it might be better diagnostics, but some of it might be, you know, who knows, environmental or other things. But there's a third, a third big reason that I want to mention, which I think is… we're just seeing the very beginning of now. Which are advanced diagnostics, certainly imaging, but also multi-cancer early detection blood tests. And that's where a blood sample is taken, and there are companies that… many companies that do this, and a lot more that are currently, in various stages of development, and that can detect a cancer signal in the blood. And, in fact, the FDA… there was an FDA advisory panel that, for the first time, recommended FDA approval. So that'll have a broad impact. But even today, even without FDA approval and without insurance reimbursement, people are either self-paying or their employers are paying for these blood tests. And the science is out on whether they actually detect cancer at a time and in a way that… that leads to increased survival. But in any event, once there's a positive signal, that needs… that cancer needs to be worked up, and people need to find it, diagnose it, and treat it. So, if you can imagine a funnel that's already expanding based on the aging of the population, increased incidence in younger people, and then on top of it. Lots and lots of what are sometimes referred to as the worried well, people who just want to have a screening, are really filling the top of… the top of that funnel, and increasing… increasing the demand on both diagnostic and treatment services.

 

Daniel Marino:

Well, it seems like, to me, when you really think about how cancer service line, cancer program has evolved, you know, I think it… years back, it was really about diagnosing and quickly treating. Now there's a bit of a…you know, an early identification, or maybe even a bit of a proactive prevention, if you will, around cancer screening, right? And what you're describing with this type of a blood test, yes, it's going to detect cancer early, and I guess it's, you know, in some cases, you know, it may be so early identification, even stage one, or even maybe pre-stage 1, but I would think along with that, it's got to really create a lot of mental health-related issues as well for patients. So, as I kind of think about, you know, a comprehensive cancer service line program, it really has to incorporate not only the diagnostic and therapeutic services, but then some of these other support services that really help to guide the patients. Is that an important part of the program, as you're seeing being developed?

 

 

Elizabeth:

I think you're spot on. You know, for anybody who has had a cancer scare, or knows anybody who has, oftentimes the most terrifying part is when you're in the process of maybe you have cancer, maybe you don't, and being diagnosed, and I think that that is…You know, often offsets a tremendous amount of anxiety until people can get a clear answer. Even, you know, even if it's a positive answer, you know, and then… and then have a treatment plan put in place. So I think in terms of the mental health impact of that, you're absolutely right, but it is creating these… these bottlenecks, and…a lot of, I would say, almost every organization we talk to is struggling to figure out how to organize themselves in a way where they can meet the needs of their community and the demands of… for cancer care and cancer diagnosis.

 

Daniel Marino:

If you're just tuning in, I'm Daniel Marino, and you're listening to Value-Based Care Insights. I am here today talking to Elizabeth Liebow, an expert in cancer program services, and really a national expert in developing cancer programs for healthcare organizations. Elizabeth, I wanna, I wanna…Kind of shift the conversation a little bit to, really thinking about how and where healthcare providers, healthcare organizations, health systems. Where they should think about expanding some of their services, right? Because, you know, it's sort of a little bit overwhelming, if you think about it, because there's so many different subspecialties of cancer. When you think about colon cancer, breast cancer, prostate cancer, you know, there's just numerous different, I think, I would call maybe general specialties or sub-specialties of cancer, as well as then, you know, some of the more specific, highly acute areas of cancer. When you're working with organizations, you know, I know you had mentioned understanding kind of the community need, but what are the factors that you start to work with them on as you start to think about where to place the resources on really building the cancer services? Because you certainly can't do everything. A hospital, you know, unless you're a large academic institution, you know, it's going to be difficult for you to focus on all areas of cancer. Other than the community, are there other drivers that are important as healthcare leaders are thinking about expanding their cancer program?

 

Elizabeth:

Yeah, it's a great… it's a great question, Dan, and I think that What we recommend for most systems, community, academic, rural, is to really think about placing their resources, their staffing, their providers, their equipment, in a way that meets the needs of most people most of the time. And so, that often means breaking down the way they're structured and reorganizing as a service line, so that they can think about, what do I need at each of my clinical locations? How do I bring the department… the clinical departments together? How do I break down the budget silos and the expense silos and the revenue silos so that we can think about what… what do patients need? Where are those patients? What can I deliver locally? And what is either so expensive or so rare that I need to centralize that at whatever the hub might be. And unless you have a service line structure where there are people who wake up every day and think about, how do I continue to improve with the resources I have and an increasing need. It's very hard to do that, because everybody is maximizing and optimizing for a different outcome.

 

Daniel Marino:

Yeah. Are you seeing more organizations, recruiting and employing, cancer specialists, providers, oncologists, and so forth, or are you seeing more joint venture alignment with community providers to… to allow for maybe a greater expansion of services, you know, across a community or across a region. Is one more… more prevalent than the other?

 

Elizabeth:

I don't know that I would say one is more prevalent than the other. It varies tremendously by geography. I think as, you know, as we all know, unfortunately, it's harder and harder for physicians to stay in private practice, and so we do see larger groups forming. We see those aligning, very closely with hospital systems, oftentimes, and aligning, around a vision for cancer care. We also see increasingly, physician practices joining practice aggregators and getting some support with some of the back office functions. So we're seeing all that. The other… the other trend we're seeing really a lot of is, the employment of advanced practice providers and reorganizations of care teams, so that, so that everybody's able to practice at the top of their license, so that the APPs can provide some continuity, the physicians can be pulled in for the things that only physicians can do, and that there are other members of the team, whether that's medical assistants, nurses, social workers, nutritionists, addressing some of the other needs and demands of cancer patients.

 

Daniel Marino:

Well, I think you hit on an important point there. A team-based model in cancer services, I think is really best practice, right? As you start to think about, you know, incorporating APPs and even navigators, you know, navigation, patient navigation within the whole cancer ecosystem, if you will, provides so much value to patients, right? Because not only do they not know where to go, but from a mental health perspective, it's great to know that you've got an advocate that will help you kind of guide through the system. Are you seeing more and more of that type of a service embedded in cancer programs?

 

Elizabeth:

I'm so glad you mentioned navigation, Dan, and I'm kicking myself for not mentioning it before you did. I think it's one of the most important things, not only for patients, I think that's very important for mental health and navigating increasingly complex, clinical and financial systems, but also for the provider teams, who, you know, oftentimes have to figure out where is the patient going next, how am I going to get them there, how soon do they need an appointment? And navigation… expert navigation can really do a lot of that. So we are seeing more and more of that. It also helps with some of the sub-specialization in large enough programs. You can have navigators that really know how to navigate GI cancers, or thoracic cancers, or blood cancers.

 

Daniel Marino:

Yeah, just providing such a value to the patient, and just creating overall just the efficiency, right, of a lot of the care that's being incorporated in the program. I want to get your opinion on one other area. A few years back, I had an opportunity to work with, a fairly large cancer program, and it was… it was helped to… to kind of manage the, at that time, the, oncology care program that was released by CMS a few years back, and one of the things that this particular program struggled with was as patients became, you know, got their services and care through the cancer program, they really looked to their oncologists, their medical oncologists, as really more of their, you know, their primary care physician. And what the program struggled with was they wanted to continue to provide that level of support, you know, the primary care support to the patients, wrapped around a lot of their you know, their cancer care and their future treatments and so forth, yet it created a bit of a burden on the oncologists. So, part of what this program did was really take a number of primary care physicians and embed them in the cancer program. And I'll tell you, it worked out really well, because it was a way for the oncologist to do a handoff to primary care. And the primary care was really embedded into the program. So, so it helped, again for providing a great service to the patient to have these other non-cancer-related chronic diseases, if you will, managed, but within the lens of the cancer service. Are you seeing that? Is that a trend, or was that kind of a one-off, or where does primary care, you know, ideally fit within a cancer program?

 

Elizabeth:

We are seeing more of that, and it's, it's a… it's a great approach, I think, that provides both the patient… you know, once… once you have a life-defining illness like cancer, you don't ever not have it, right? So you have to… you have to follow patients and… and their concerns that it's going to recur over their lifetime. But that's not the only thing that patients are exposed to, and you have to test for all of the other things. So I think, as you're saying, embedding primary care is one thing that we're seeing, and it's a wonderful way to do it. Other things that we're seeing that have success are again, the use of advanced practice providers, either embedded within a cancer practice, or sometimes running a specific survivorship clinic. And it'll also be interesting to see, you know, at least on the sort of technical side, what AI and post-treatment plans can look like. That won't address the personal part of the connections that often develop between oncologists and patients during that really intense time of treatment, but it may address some of the capacity issues, because, as we know, there's a shortage of PCPs as well.

 

Daniel Marino:

Well, it seems to me, like, with many areas of healthcare, I think AI is going to have a pretty big influence on cancer services. You know, as we talked about, possibly to identify cancers early, but I think, you know, from what I've been able to see in some of the, both the science… scientists as well as the medical professionals, it's gonna allow us to create a more focused treatment plan on the specific cancers. Is that the role you're seeing with AI, or is there additional functionality or capabilities that you're seeing that's influencing some of the cancer care?

 

Elizabeth:

I think AI is influencing every aspect of cancer care. Not entirely in positive ways, but I think largely in positive ways. Everything from, you know, AI-assisted diagnostics through, easier-to-access treatment plans. You know, cancer, it's so…As we talked about at the beginning, it's so complicated that no one person can keep it all in their head, so having it you know, best practices that can be updated almost as quickly as they're approved, is tremendously helpful to have at people's fingertips. Yeah. And then I think, you know, the treatment summary, so all of that.

 

Daniel Marino:

It all feeds right into that, and I agree with you. I think it's… I think we're just at the tip of the iceberg right now, to see really what AI can do, and how it's going to influence cancer care, and, you know, I think it's, I think it's quite encouraging to see not only how far we've come, but really how far we can go. I'm being able to incorporate this technology. So, as organizations are thinking about expanding their cancer program. Focusing on maybe better supporting the community, or maybe their independent providers who are providing cancer services. What's some of the advice that you give to these healthcare leaders on where to start? I mean, it's a little bit overwhelming, right? And it's sort of like boiling the ocean, because there's so many different areas that you want to begin in order to provide the service. Is there a recommended starting point, or how do you approach it with healthcare strategists who are really thinking about expanding the service?

 

Elizabeth:

As, you know, notwithstanding our conversation about AI, cancer care is still… the most important piece of it is the physician and the patient and their relationship, and we really are facing a crisis of capacity and a shortage of physicians. So I would start with the physician piece, and ask, you know, is there sufficient capacity? Is the… is the service structured today in a way that the physicians can be efficient, that they don't burn out, that they can provide the best care that they want to provide. Asking all of those questions, are they compensated adequately for 2026-27? And are they incentivized correctly, right? Is it… are they incentivized to just generate as many RVUs as possible, or are they incentivized to think about team care? Are they incentivized around wait times? So, thinking… we… we're seeing increasingly… in fact, I would… it was just a…panel discussion on this. Organizations taking a step back and saying, what are we really trying to accomplish, as we meet the need, and how, you know, how are our physicians being, being part of that and leading that, and are they getting what they need in order to take care? So that's where I would start. I think the second thing I would say is to, to really start with measuring how long it takes your system to get a patient from the first suspicion of cancer to a clear diagnosis and treatment. Because there are so many things that can go wrong in that short period of time. And again, unless you've got someone who wakes up every day and says am I… you know, 7 days? Am I at 150 days? And where does my system want to be, and how do I get there? You really leave it up to each individual area to… to do the right thing, but not to bring… necessarily to bring it all together.

 

Daniel Marino:

Well, that kind of gets back to what you were saying before, right? The navigation, I think, is really key, and to help ensure that we are going at the right pace of servicing the patients. Well, Elizabeth, this has been great, and you know, clearly a very important topic for healthcare in general, but specifically for patients and for communities, and for the healthcare providers. If any of our listeners are interested in learning more would you mind sharing your contact information, email, or LinkedIn?

 

Elizabeth:

Sure, happy to do that. My email is E-A-L-I-E-B-O-W at ECGMC.com.

 

Daniel Marino:

Well, Elizabeth, I want to thank you for coming on the program, having this conversation. Again, an area that I agree, it's important. I think this certainly won't be the last time we talk about it here, and would love to have you back again to kind of dive into, you know, some specific areas of some areas that we talked about today.

 

Elizabeth:

That's great. I'd love to do that. I feel like there's so much more we could dive into, so it'd be a pleasure to come back.

 

Daniel Marino:

Thank you, and a special thanks to our listeners for tuning in. We appreciate it, and like we say, if you're interested in learning a little bit more about this topic, or any of the topics that we talk about in Value-Based Care Insights, please log on to luminahp.com/insights or ECGMC.com. Until our next insight, I am Daniel Marino bringing 30 minutes of value to your day. Take care.

About Value-Based Care Insights Podcast

Value-Based Care Insights is a podcast that explores how to optimize the performance of programs to meet the demands of an increasingly value-based care payment environment. Hosted by Daniel J. Marino, the VBCI podcast highlights recognized experts in the field and within Lumina Health Partners

Daniel J. Marino

Podcast episode by Daniel J. Marino

Daniel specializes in shaping strategic initiatives for health care organizations and senior health care leaders in key areas that include population health management, clinical integration, physician alignment, and health information technology.